| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |